Gazyva Placebo, Gazyvaro 1,000 mg concentrate for solution for infusion.
CA42750
Phase 3 small_molecule active
Quick answer
Gazyva Placebo, Gazyvaro 1,000 mg concentrate for solution for infusion. for Systemic Lupus Erythematosus (SLE) is a Phase 3 program (small_molecule) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Roche Registration Limited
- Indication
- Systemic Lupus Erythematosus (SLE)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active